Glassy Trial for Effects of Wearing Glasses
Communicating Uncertainty About the Effects of Wearing Glasses to Reduce the Chance of Getting COVID (Corona Virus Disease): Protocol for a Randomized Trial
2 other identifiers
interventional
960
1 country
1
Brief Summary
Randomized trial testing 6 forms of a communication summarizing the results of a recent study (about the effects of wearing glasses on reducing covid infection risk). The goal of the trial is to test the effect of different language options to describe uncertainty, and of including the margin of error around the main result.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Dec 2022
Shorter than P25 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedMay 22, 2024
May 1, 2024
2 months
November 30, 2022
May 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
understanding of overall uncertainty of benefit (of wearing glasses to reduce the chance of covid infection)
How sure about the effect (4 point scale from very unsure to very sure)
within 1 day
understanding of overall uncertainty of harm (of wearing glasses to reduce the chance of covid infection)
How sure about the effect (4 point scale from very unsure to very sure)
within 1 day
sufficiency of what is known about the effects of wearing glasses to reduce the chance of covid infection
How sure about the effect (4 point Likert scale)
within 1 day
Understanding the margin of error around the benefit of wearing glasses to reduce covid
this is a co-primary outcome which will be used only to compare the 3 versions that include the margin of error to the 3 versions that do not
within 1 day
Secondary Outcomes (13)
perceived effect of wearing glasses to reduce chance of covid infection
within 1 day
how likely is it that wearing glasses reduces the chance of covid infection
within 1 day
intended behavior (if there were a surge in covid in your area, how likely would you be to wear glasses to reduce the chance of covid infection
within 1 day
intended behavior (if there were very few cases of covid in your area, how likely would you be to wear glasses to reduce the chance of covid infection
within 1 day
perceptions fo information provided (trustworthy summary?)
within 1 day
- +8 more secondary outcomes
Study Arms (6)
GRADE + margin of error
ACTIVE COMPARATOROverall uncertainty using GRADE\* language AND margin of error around main result \* Based on the Cochrane Effective Practice and Organisation of Care Group's guidance for communicating the certainty of evidence based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assessing the certainty of evidence
Colloquial language AND margin of error
ACTIVE COMPARATORColloquial language developed to describe overall study uncertainty AND margin of error around main result
No overall uncertainty language AND margin of error
ACTIVE COMPARATORNo overall uncertainty language AND margin of error around main result
GRADE -No margin of error
ACTIVE COMPARATOROverall uncertainty using GRADE\* language and NO margin of error around main result \* Based on the Cochrane Effective Practice and Organisation of Care Group's guidance for communicating the certainty of evidence based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assessing the certainty of evidence
Colloquial - No margin of error
ACTIVE COMPARATORColloquial language developed to describe overall study uncertainty and NO margin of error around main result
No overall uncertainty language AND no margin of error
PLACEBO COMPARATORNo overall uncertainty language and NO margin of error around main result
Interventions
Researchers are testing different forms of information about overall study uncertainty and margin of error around main result
Eligibility Criteria
You may qualify if:
- \>= 18 years old
- literate in English or Norwegian
- currently residing in Norway or the United States
You may not qualify if:
- individuals who regularly wear any kind of glasses (i.e., prescription or sunglasses) all or most of the time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Norwegian Institute of Public Health
Oslo, Norway
Related Publications (1)
Holst C, Woloshin S, Oxman AD, Rose C, Rosenbaum S, Munthe-Kaas HM. Alternative Presentations of Overall and Statistical Uncertainty for Adults' Understanding of the Results of a Randomized Trial of a Public Health Intervention: Parallel Web-Based Randomized Trials. JMIR Public Health Surveill. 2025 Mar 18;11:e62828. doi: 10.2196/62828.
PMID: 40101228DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Woloshin, MD
Dartmouth Institute for Health Policy and Clincal Practice
- PRINCIPAL INVESTIGATOR
Andy Oxman, MD
Norwegian Institute of Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2022
First Posted
December 8, 2022
Study Start
December 1, 2022
Primary Completion
January 31, 2023
Study Completion
March 31, 2023
Last Updated
May 22, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share